Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > This is how existing shareholders should be treated

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Jan 30, 2021 7:42pm

150 Views

Post# 32429743

RE:RE:RE:RE:RE:RE:RE:RE:This is how existing shareholders should be treated

You are welcome! This is my opinion only and I am not giving any financial advices but as you have been reading what has been said here all of us although having different opinions re how the company should run their business have one thing in common we are still invested in the company (otherwise we wouldn't be here) therefore we are still believing the company is a good investment.

balmusette wrote: Thank you Scarlet,

So averaging down, waiting for the medium and long term seems to be a sensible strategy at this point ; the shares are cheap.

<< Previous

Bullboard Posts

Next >>

Nextech CEO provides company update on Amazon deal and more